The spontaneously hypertensive/NIH-corpulent (SHR/N-cp) rat is a genetic animal model that exhibits obesity, metabolic features of hyperinsulinemia, hyperglycemia, and hyperlipidemia, which are characteristic of type II diabetes and mild hypertension. To determine the role of leptin, the protein product of the ob gene, in the development of obesity and diabetes in this model, we measured steady-state circulating levels of leptin in obese and lean SHR/N-cp rats and examined the relation between plasma leptin levels and metabolic variables at the stage of established obesity in these animals. Mean fasting plasma leptin concentration was 8-fold higher in obese than in lean rats (p0.01).
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This was associated with a 6-fold elevation in plasma insulin in the obese group. Fasting levels of plasma glucose, cholesterol, and triglyceride were all significantly higher in obese rats than in lean controls. Spearman correlation analysis showed a significant positive correlation between plasma leptin concentration and body weight among the animals (r=0.73, p0.01). Similarly, plasma insulin concentration was significantly correlated with BW in all animals (r=0.54, p0.05). There was also a significant positive correlation between plasma leptin and plasma insulin in the entire group (r =0.70, p K0.01). However, this relationship was significant only for lean rats but not for obese rats (r=0.59, p K0.05 for lean rats, and r =0.23, p NS, for obese rats). Plasma leptin also correlated positively with fasting plasma glucose (r =0.75, p 0.05), total cholesterol ( [14] [15] [16] [17] The spontaneously hypertensive/NIH-corpulent (SHR/N-cp) rat is a genetic animal model that exhibits obesity, metabolic features of hyperinsulinmia, hyperglycemia, and hyperlipidemia characteristic of NIDDM, and mild hypertension. [18] [19] [20] [21] Unlike other rodent models of obesity, the SHR/N-cp rat is a congenic strain. This was achieved by an initial mating of a male obese spontaneously hypertensive (Koletsky) rat which was heterozygous for the cp gene with a spontaneously hypertensive rat (SHR) of the Okamoto strain, followed by multiple rounds of back-crossing of the progeny to the SHR strain. [19, 2] Table II . There was wide variability in plasma leptin and plasma insulin levels among the animals. Individual levels of plasma leptin were positively correlated with body weight among all rats (r=0.73, p<0.01) (Fig. 1) . Similarly, plasma insulin concentration was and Zucker (fa/fa) rats. [14] [15] [16] More relevant to the present study is the finding by Hiraoka and co-workers I251 of a marked increase in ob gene expression and leptin secretion in the obese SHR or Koletsky rat, the parent strain from which the SHR/N-cp rat was originally derived. In their study, plasma leptin levels were found to be 100-fold higher in obese than in lean SHRs, whereas in our study, serum leptin levels were about 8-fold higher in obese SHR/N-cp rats compared with their lean littermates. Additionally, Shillabeer et al. [26] reported increased mRNA leptin levels in proportion to adipocyte number in JCR: LA-corpulent rats, a substrain which is also derived from obese SHR.
Obese SHR/N-cp rats also exhibited marked hyperinsulinemia, mild hyperglycemia, hypercholesterolemia, and hypertriglyceridemia, as has been observed in previous studies. I18 ' 19] We have previously reported that the hyperinsulinemia in obese rats is associated with marked hyperplasia of pancreatic ]3-cells. I21 In the present study, the marked hyperinsulinemia in obese SHR/N-cp rats was associated with marked elevations in fasting serum leptin concentrations, suggesting an interaction between these two hormones in the development of obesity. Insulin has recently been suggested to play an important role in the regulation of leptin secretion, in addition to its contributory role in the development of obesity in animals and humans. Studies in rats with insulin deficiency induced by streptozotocin have shown that plasma leptin levels and leptin mRNA are markedly reduced and treatment with insulin in these animals restores leptin levels to normal. I271 Acute and chronic administration of insulin has been shown to increase ob mRNA expression in other experimental animals. [21, 28] We also observed a significant positive correlation between plasma leptin concentration and fasting levels of plasma glucose, total cholesterol, and triglycerides. These results extend the recent observations by Haffner et al. [29] in male non-diabetic human subjects showing a significant correlation of serum leptin levels with whole-body glucose disposal rate (GDR), fasting glucose, total triglycerides, apolipoprotein B, and low density lipoprotein (LDL) size. Similar correlations between serum leptin levels and body fat content, fasting insulin, fasting glucose, and triglycerides have been reported by Iida et al. [3] in studies of the Otsuka-Long-Evans Tokushima-Fatty (OLETF) rat, another rodent model of spontaneous NIDDM. Thus, it appears that high circulating leptin may also be associated with metabolic risk factors that are related to insulin resistance.
In contrast to the stimulatory effects of insulin on leptin secretion, leptin has been shown in many studies to inhibit insulin release. [8'31'32] This effect of leptin appears to be a direct inhibitory action of the hormone on leptin receptors (ObRb) present in pancreatic -cells. [31'32] This interaction between insulin and leptin has led to the hypothesis recently proposed by Kieffer and 
